Does DARATUMUMAB Cause Thrombocytopenia? 1,089 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,089 reports of Thrombocytopenia have been filed in association with DARATUMUMAB (DARZALEX). This represents 4.0% of all adverse event reports for DARATUMUMAB.
1,089
Reports of Thrombocytopenia with DARATUMUMAB
4.0%
of all DARATUMUMAB reports
199
Deaths
374
Hospitalizations
How Dangerous Is Thrombocytopenia From DARATUMUMAB?
Of the 1,089 reports, 199 (18.3%) resulted in death, 374 (34.3%) required hospitalization, and 114 (10.5%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
Neuropathy peripheral (955)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which DARATUMUMAB Alternatives Have Lower Thrombocytopenia Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE